Related Experiment Videos
Radiotherapy gaps and new frontiers in the Commonwealth
Mei Ling Yap1, Danielle Rodin2
1Collaboration for Cancer Outcomes, Research and Evaluation, Ingham Institute for Applied Medical Research, South-Western Sydney Local Health District, Liverpool, NSW, Australia; The George Institute for Global Health, Barangaroo, NSW 2000, Australia; School of Medicine, Western Sydney University, Campbelltown, NSW, Australia.
The Lancet. Oncology
|October 3, 2024
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Sex and gender reporting in Australian cancer clinical trials: are we doing enough?
Research integrity and peer review·2026
A Prospective Population-Based Study of Chimeric Antigen Receptor T-Cell Therapy for Patients with Diffuse Large B-Cell Lymphoma.
Current oncology (Toronto, Ont.)·2026
Sustained use and determinants of telehealth in metropolitan cancer care: A multi-centre retrospective study beyond the COVID-19 pandemic.
Journal of telemedicine and telecare·2026
The role of stereotactic body radiotherapy in oligoprogressive breast cancer: A site-specific analysis of the prospective, phase-II RADIANT trial.
Clinical and translational radiation oncology·2026
Time toxicity in patients receiving brachytherapy and hormonal therapy for recurrent prostate cancer: a cohort study.
BMJ supportive & palliative care·2026